Mercer Global Advisors
CNSY

Mercer Global Advisors’s Cerenome CNSY Stock Holding History

Mercer Global Advisors’s Portfolio CNSY Stock Details CNSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-2,564
Closed -$10.4K – 3745
2026
Q1 		$10.4K Buy
+2,564
New +$19.4K ﹤0.01% 3205
2025
Q4 		– Sell
-1,139
Closed -$19.5K – 2950
2025
Q3 		$19.5K Buy
+1,139
New +$14K ﹤0.01% 2620

Other funds holding CNSY

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
ATPW
Ashton Thomas Private Wealth Scottsdale, Arizona $4.79B AUM 27.94% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Mercer Global Advisors's CNSY Position: Q2 2026 in Review

Mercer Global Advisors sold out of Cerenome (CNSY) in Q2 2026, closing a stake of 2,564 shares — an estimated $10.4K sold.

Mercer Global Advisors first reported a position in CNSY in Q3 2025 and held it in 2 quarters. The position peaked at $19.5K in Q3 2025. 21 funds tracked by Wall St. Rank hold CNSY as of Q2 2026.

  • Mercer Global Advisors reported no remaining Cerenome position as of Q2 2026 after selling out during the quarter.
  • Mercer Global Advisors sold 2,564 Cerenome shares in Q2 2026, an estimated $10.4K.
  • Mercer Global Advisors first reported a position in Cerenome in Q3 2025 and held it in 2 quarters.
  • Mercer Global Advisors's Cerenome position peaked at $19.5K in Q3 2025.
  • 21 funds tracked by Wall St. Rank held Cerenome as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.